InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Nash Duane, Président Exécutif. Insider active across 1 company, notably Immunic, INC.. Aggregated, 5 filings have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €150k. Activity tracked since 12 May 2021. The latest transaction was disclosed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
10,000 shares@ US$5.030.029% mcap32.4% of flowCommon StockSEC:0001193805-22-000787:0
Ideal exit: 6 Feb 2023 (T+270)
1,000 shares@ US$9.800.0051% mcap5.6% of flowCommon StockSEC:0001193805-21-001159:0
Ideal exit: 7 May 2022 (T+270)
1,000 shares@ US$9.805.6% of flowCommon StockSEC:0001193805-21-001159
Ideal exit: 7 May 2022 (T+270)
4,000 shares@ US$12.7528.2% of flowCommon StockSEC:0001193805-21-000654
Ideal exit: 6 Feb 2022 (T+270)
4,000 shares@ US$12.750.026% mcap28.2% of flowCommon StockSEC:0001193805-21-000654:0
Ideal exit: 6 Feb 2022 (T+270)
5 of 5 declarations
About Nash Duane
Duane Nash is the Executive Chairman at Immunic, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His experience is valuable for the development of Immunic.
